Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

MYGNMYGN
Showing 8 of 20 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in MYRIAD GENETICS INC

Yes. Connor, Clark & Lunn Investment Management holds 1,407,860 shares of MYGN (Myriad Genetics), worth $8M, as of its Q2 2026 13F filing. It increased the position by 89,197 shares (+6.8%) from Q1 2026. Connor, Clark & Lunn Investment Management has held MYGN since Q2 2024, across 9 quarterly 13F filings.

Current Value

$8M

Current Shares

1.4M

Total Value Change

+$4.9M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+6.8%
$8M0.0%$5.71
29
2026-Q1
Increased
1.3M
+14.0%
$5.9M0.0%$4.50
31
2025-Q4
Decreased
1.2M
-9.4%
$7.1M0.0%$6.15
0
2025-Q3
Decreased
1.3M
-8.0%
$9.2M0.0%$7.23
0
2025-Q2
Increased
1.4M
+50.5%
$7.4M0.0%$5.31
38
2025-Q1
Increased
921,911
+67.8%
$8.2M0.0%$8.87
41
2024-Q4
Increased
549,456
+377.6%
$7.5M0.0%$13.71
44
2024-Q3
Increased
115,036
+426.1%
$3.2M0.0%$27.39
43

Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used